Phibro Animal Health Corporation Revenue per Employee (PAHC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Phibro Animal Health Corporation  (NASDAQ: PAHC)
 

Phibro Animal Health's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 4.4% in the fourth quarter 2026, year on year to cumulative value of $1,517 million, Phibro Animal Health's revenue per employee grew on a trailing twelve months basis to $ 582,288, this marks a new company high.
Within the Healthcare sector Employees of 149 other companies have achieved higher revenue per employee. While Phibro Animal Health's total ranking has deteriorated compared to the previous quarter from 747 to 1414. Phibro Animal Health has 2,605 employees.


What is Sales per Employee Ratio?







PAHC Revenue per Employee (Jun 30 2026)
IV. Quarter
(Mar 31 2026)
III. Quarter
(Dec 31 2025)
II. Quarter
(Sep 30 2025)
I. Quarter
(Jun 30 2025)
IV. Quarter
Y / Y Revenue Change 4.4 % 10.1 % 20.98 % 40.19 % 38.61 %
Sales per Employee (TTM) $ 582,288 575,863 562,386 537,516 497,483
PAHC's Total Ranking # 1414 # 747 # 114 # 1005 # 1148
Seq. Revenue Change 3.68 % 2.41 % 2.71 % -4.27 % 9.33 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 97
Healthcare Sector # 150
Overall Market # 1414

Revenue per Employee Statistics
High Average Low
$ 582,288 $ 355,943 $ 286,873
(Jun 30 2026)   (Mar 31 2016)



Financial Statements
Phibro Animal Health's Revenue MRQ $ 397 Millions Visit PAHC's Income Statement
Phibro Animal Health's Revenues TTM $ 1,517 Millions Visit PAHC's aggregate revenue growth
What are PAHC's Sales? Visit PAHC's Sales by Segment




Other Ratios
Phibro Animal Health's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PAHC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PAHC's Competitors
Revenue per Employee for PAHC's Suppliers
Revenue per Employee for PAHC's Customers

You may also want to know
PAHC's Sales Growth Rates PAHC's Pe Price to earnings ratio PAHC's Receivables Turnover Ratio PAHC's Stock Quote
PAHC's Net Income Growth Rates PAHC's Ps Price to Sales ratio PAHC's Sales per Employee PAHC's Asset Turnover Ratio
PAHC's Net Margin PAHC's Pb Price to Book ratio PAHC's Financial Strength Ratios PAHC's Dividend Payout Ratio
Date modified: 2026-09-08T15:22:21+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Ptc Therapeutics inc   1,017,915.24 $ 1,008.754  Million 991 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Regeneron Pharmaceuticals Inc   1,008,092.15 $ 15,534.700  Million 15,410 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Carlisle Companies Incorporated  863,898.31 $ 5,097.000  Million 5,900 
Verastem Inc   858,098.04 $ 87.526  Million 102 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Vir Biotechnology Inc   826,231.61 $ 303.227  Million 367 
Immunocore Holdings Plc  822,089.69 $ 430.775  Million 524 
Prothena Corporation Public Limited Company  813,880.60 $ 54.530  Million 67 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Sanuwave Health Inc   798,236.36 $ 43.903  Million 55 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.